Search

GLP-1’s for Everything! The gift that keeps on giving… A review of the body of evidence and implications for managed care
Oncology Pipeline 2025: Emerging Breakthroughs and Trends
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice, Managed Care Insights into IgA Nephropathy and Duchenne Muscular Dystrophy
Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice, Managed Care Insights into Sickle Cell Disease and Hemophilia
Advancing Schizophrenia Management Strategies in the Patient Journey: Treatment Innovations, Adherence, and Health Outcomes
Advancing Equitable Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) Management Strategies in Managed Care
Charting a Better Path in Managing Multiple Myeloma: Overcoming Challenges and Driving Solutions
Mind Over Migraines: Disease Burden, Innovative Therapies, and Managed Care Trends in Treating Migraines
Tuesday, 4/14 - Sessions from 10:15-11:30am
(D1) Next-Generation HIV PrEP: Therapeutic Advances, Adherence Optimization, and Policy Updates for Managed Care
(L1) The Fine Print of Affordability: What Employers and PBMs Need to Know About Cost-Shifting Strategies
(M1) Oncology in Focus: What’s Hot, What’s Next!
(R1) RWE in Action: Using the AMCP RWE Standards to Facilitate Formulary Decisions
(W1) Beyond the Buzzwords: Lessons Learned in Bridging Pharmacy, Quality, AI, and Data Science to Improve Performance
Tuesday, 4/14 - Sessions from 1:30-2:45pm
(D2) Beyond the Breakthrough: Practical Insights for the Complex Gene Therapy Market
(L2) Federal Legislative and Regulatory Update
(M2) The Accelerated Approval Program: Balancing Crucial Patient Access with Timely Evidentiary Needs
(R2) Launch to Lessons Learned: Real-World Experience with Adalimumab Biosimilars
(W2) Driving Quality in Oncology Medication Use Through Precision Medicine
Tuesday, 4/14 - Sessions from 3:15-4:15pm
(F3) Mission Possible: How Integrated Medical & Pharmacy Benefits Can Improve Specialty Drug Management
(L3) An Enterprise Solution for Mental Health Parity Compliance
(W3) Patient Experience Data in Managed Care Pharmacy Decision Making: Barriers, Opportunities, and Practical Strategies for Managed Care Pharmacists
(K1) 2025-2026 Health Care and Pharmaceutical Marketplace Trends

Pages